Without further ado, let’s get started.
Despite prohibitionists’ often-expressed fears that legalization would lead more young people to use marijuana, new federal data released on Tuesday shows no such trend.
Reports of past-month cannabis use among those 12-17 remained stable from 2017 to 2018—and they’re significantly lower than in the years prior to when the first states began legalizing for adult use.
Cannabis concentrates have been growing in popularity among marijuana enthusiasts, especially among those that want a strong, potent dose of CBD.
Whether you are using cannabis to assist with medical treatment or just like to de-stress and relax, CBD concentrate is one of the most effective ways to get a high dose of CBD at an affordable price.
The FBI’s announcement that it is probing public corruption in the legal marijuana industry has stirred up strong reactions among cannabis insiders.
While some complain the FBI’s scrutiny is another example of how the legal MJ industry is being unfairly targeted as if it’s a bottomless gold mine, others welcome the feds’ attention to illicit influence on licensing decisions.
Fifty new retail cannabis licences will be awarded on Tuesday as Ontario moves forward with its second lottery.
The lottery will be handing out licences to sell legal marijuana to 42 retail stores, including 13 in Toronto and six in the rest of the GTA, while eight more will be given to First Nations Reserves through a separate, first-come first-serve basis system.
It’s been an eventful week for German medical cannabis distributor Iuvo Therapeutics.
By becoming EU-GMP certified and exporting to the European Union, TerrAscend joined the select group of Canadian cannabis producers already certified that include:
- Aurora Cannabis (TSX: ACB) (NYSE: ACB) | Aurora Cannabis Enterprises and MedReleaf
- Canopy Growth (TSX: WEED) (NYSE: CGC) | Tweed Farms and Tweed
- Cronos Group (TSX: CRON) (NASDAQ: CRON) | Peace Naturals Project
- Tilray (NASDAQ: TLRY) | Tilray Canada
- Wayland Group (CSE: WAYL) (OTCPK: MRRCF) | Maricann
Up and down the Eastern United States, cannabis growers and business owners are reporting healthy prices for pounds of marijuana, both medical and recreational.
Waiting time for cannabis research licences stalling progress on understanding plant’s possibilities
Health Canada recently shared with Science Mag that its goal for approving licensing is “42-day turnaround, with a 180-day response time” for multiple research protocols. “We expect the weekly number to grow in the coming weeks,” a Health Canada spokesperson said.
This month scientists from Harvard University’s Dana-Farber Cancer Institute have released some much-needed good news.
In their study, published in the journal Frontiers of Oncology on July 23, the researchers revealed that a chemical found in cannabis has demonstrated “significant therapy potential” in treatment of pancreatic cancer.
The National Credit Union Administration (NCUA) officially declared that credit unions are safe to service law-abiding hemp companies.
Here’s the groundbreaking Federal announcement in the NCUA’s own words:
Two top federal drug officials, including the White House drug czar, recently said that marijuana legalization should be left up to states.
The comments stand out coming from the Office of National Drug Control Policy (ONDCP), which has historically played a central role in defending blanket federal prohibition.
Move over Canopy. The world’s largest cannabis company is set to IPO in less than 30 days.
Get the full details here so you don’t miss out on the next potential 10 bagger.